Skip to Content
  1. All products
  2. GLP-1 Medications
  3. Tirzepatide (Mounjaro)
  4. GLP-1 Medications
Pricelist: Default Pricelist
Pricelist: Default Pricelist
RX
Tirzepatide (Mounjaro)

Tirzepatide (Mounjaro)

Dual GLP-1/GIP agonist for enhanced weight loss by Eli Lilly. Consult your doctor for dosage.
₹ 12,075.00 ₹ 13,125.00

  • Dosage
  • Manufacturer
Manufacturer: Eli Lilly and Company

Mounjaro® contains tirzepatide, a medication that activates both GIP and GLP-1 receptors. These hormones help regulate blood sugar levels, appetite, and energy metabolism.

Mounjaro is prescribed for adults with type 2 diabetes to improve blood sugar control and may also support significant weight reduction and metabolic improvements.


How Mounjaro Works

Mounjaro uses a dual-hormone mechanism targeting both GIP and GLP-1 receptors.

This helps the body by:

• Increasing insulin release when blood sugar levels rise

• Reducing glucose production from the liver

• Slowing digestion to improve fullness

• Reducing appetite and calorie intake

This combined action helps support better glucose control and metabolic health.


How It’s Taken

Mounjaro is administered as a once-weekly injection under the skin.

Common injection sites include:

• Abdomen

• Thigh

• Upper arm

Treatment usually begins with a lower starting dose that gradually increases based on medical guidance.


Potential Benefits

Mounjaro may help:

• Improve blood sugar control

• Support weight reduction

• Reduce appetite and calorie intake

• Improve metabolic health markers


Common Side Effects

Some individuals may experience side effects, particularly during early treatment.

Common side effects include:

• Nausea

• Diarrhea

• Vomiting

• Constipation

• Decreased appetite

• Abdominal discomfort

These symptoms are typically temporary and improve as the body adapts to treatment.


Safety Information

Before starting Mounjaro, inform your doctor if you have a history of:

• Pancreatitis

• Thyroid cancer

• Severe gastrointestinal conditions

Mounjaro should not be used by individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).

Always discuss current medications, supplements, and health conditions with your healthcare provider before treatment.


Missed Dose

If a dose is missed:

• Take the missed injection within 4 days of the scheduled time

• If more than 4 days have passed, skip the missed dose and continue with the next scheduled injection

Do not take two doses at the same time.


Key Facts

Drug Class: Dual GIP and GLP-1 Receptor Agonist

Administration: Once-weekly injection

Primary Use: Type 2 diabetes management

Habit Forming: No

Common Questions

Answered
directly.

GLP-1 medication is not prescribed universally. Every patient undergoes a thorough clinical evaluation — reviewing medical history, current conditions, and relevant investigations — before any prescription is made. The decision is always made by the doctor, not an algorithm.

Clinical data shows patients on GLP-1 therapy lose around 12–15% of body weight during treatment when combined with dietary guidance. Results vary depending on physiology, adherence, and dosage.

If suitable, your doctor creates a personalised dosing protocol. You receive a prescription, monitoring schedule, and direct access to your care team. Early treatment usually includes weekly check-ins.

GLP-1 medication works with the body's appetite signals, meaning rigid dieting often becomes unnecessary. Your doctor will provide practical nutritional guidance that complements the medication.

The most common side effects are nausea, mild fatigue, and appetite changes in the early weeks. These are managed by starting with a low dose and adjusting gradually under medical supervision.

Treatment duration varies. Some patients continue for 12–18 months, while others transition to maintenance earlier. The timeline depends on your medical progress.